Certified by Founder Lodge
RA Capital Management, L.P.
United States - Boston, MA INVESTOR
1 Disclosed Funding Rounds $160,000,000
191 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing
| Company | Date | Round | Raised |
|---|---|---|---|
 Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
 Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
 Boundless Bio | May, 17 ,2023 | Series C | $100,000,000 |
 Septerna | July, 18 ,2023 | Series B | $150,000,000 |
 Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
 Carmot Therapeutics, Inc. | July, 26 ,2022 | Series D | $160,000,000 |
 Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
 Convergent Therapeutics, Inc. | May, 04 ,2023 | Series A | $90,000,000 |
 ExcepGen | August, 25 ,2023 | Unknown | $4,000,000 |
| Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
 Pluton Biosciences | May, 25 ,2023 | Series A | $16,500,000 |
 Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
 Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
 NAPIGEN, INC. | July, 12 ,2022 | Seed | $7,900,000 |
 Hemab Therapeutics | February, 22 ,2023 | Series B | $135,000,000 |
 Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Boundless Bio | May, 17 ,2023 | Series C | $100,000,000 |
 Superluminal Medicines Inc. | September, 04 ,2023 | Seed | $33,000,000 |
| ExcepGen | August, 25 ,2023 | Unknown | $4,000,000 |
 SpyGlass Pharma, Inc. | July, 11 ,2023 | Series C | $90,000,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
 Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
 Bicara Therapeutics | March, 07 ,2023 | Series B | $108,000,000 |
 Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Pluton Biosciences | May, 25 ,2023 | Series A | $16,500,000 |
 Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
| Septerna | July, 18 ,2023 | Series B | $150,000,000 |
| Superluminal Medicines Inc. | September, 04 ,2023 | Seed | $33,000,000 |
 AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
 Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
| SpyGlass Pharma, Inc. | July, 11 ,2023 | Series C | $90,000,000 |
| Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
 Selux Diagnostics, Inc | March, 01 ,2022 | Series C | $50,000,000 |
| Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
| Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
 FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
 Cortica | April, 19 ,2023 | Unknown | $75,000,000 |
| Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
| Septerna | July, 18 ,2023 | Series B | $150,000,000 |
| ExcepGen | August, 25 ,2023 | Unknown | $4,000,000 |
| Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
 Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Convergent Therapeutics, Inc. | May, 04 ,2023 | Series A | $90,000,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
| Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
| Superluminal Medicines Inc. | September, 04 ,2023 | Seed | $33,000,000 |
| Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
 Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Boundless Bio | May, 17 ,2023 | Series C | $100,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
| Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
| ExcepGen | August, 25 ,2023 | Unknown | $4,000,000 |
 Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Pluton Biosciences | May, 25 ,2023 | Series A | $16,500,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
| Superluminal Medicines Inc. | September, 04 ,2023 | Seed | $33,000,000 |
 Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| SpyGlass Pharma, Inc. | July, 11 ,2023 | Series C | $90,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
| Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
| Septerna | July, 18 ,2023 | Series B | $150,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
| Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| ExcepGen | August, 25 ,2023 | Unknown | $4,000,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Superluminal Medicines Inc. | September, 04 ,2023 | Seed | $33,000,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| Star Therapeutics | September, 05 ,2023 | Series C | $90,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
 Gameto | May, 30 ,2024 | Series B | $33,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
 Adcytherix | June, 12 ,2024 | Seed | $32,219,580 |
| Mariana Oncology | September, 08 ,2023 | Series B | $175,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
 Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
 Vesta Healthcare | September, 05 ,2024 | Series C | $65,000,000 |
| Vaxess Technologies | September, 14 ,2023 | Unknown | $9,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
 Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Adela, Inc. | September, 26 ,2023 | Unknown | $48,000,000 |
 Be Biopharma | October, 23 ,2024 | Unknown | $82,000,000 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
 Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| Commons Clinic | October, 10 ,2023 | Series A | $19,500,000 |
| Gameto | May, 30 ,2024 | Series B | $33,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| Adcytherix | June, 12 ,2024 | Seed | $32,219,580 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Vesta Healthcare | September, 05 ,2024 | Series C | $65,000,000 |
| Ventricle Health | October, 20 ,2023 | Seed | $8,000,000 |
| Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Be Biopharma | October, 23 ,2024 | Unknown | $82,000,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
 INNOVENTRIC | October, 30 ,2024 | Series B | $28,500,000 |
| Rampart Bioscience | October, 25 ,2023 | Series A | $85,000,000 |
 Metsera | November, 14 ,2024 | Series B | $215,000,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
 Adcendo | November, 26 ,2024 | Series B | $135,000,000 |
| Aiolos Bio | October, 26 ,2023 | Series A | $245,000,000 |
 Indapta Therapeutics | December, 18 ,2024 | Unknown | $22,500,000 |
| Gameto | May, 30 ,2024 | Series B | $33,000,000 |
 Curevo Vaccine | March, 19 ,2025 | Series B | $110,000,000 |
| Forward Therapeutics, Inc. | November, 09 ,2023 | Series A | $50,000,000 |
| Adcytherix | June, 12 ,2024 | Seed | $32,219,580 |
| Nature's Toolbox, Inc. (NTx) | November, 17 ,2023 | Series B | $47,500,000 |
| Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
| AM Batteries | December, 05 ,2023 | Series B | $30,000,000 |
| Vesta Healthcare | September, 05 ,2024 | Series C | $65,000,000 |
| FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
| Sionna Therapeutics | March, 07 ,2024 | Series C | $182,000,000 |
| Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
| Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
| Be Biopharma | October, 23 ,2024 | Unknown | $82,000,000 |
| Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
| Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
| Bluejay Therapeutics | May, 10 ,2024 | Series C | $182,000,000 |
| Gameto | May, 30 ,2024 | Series B | $33,000,000 |
| Adcytherix | June, 12 ,2024 | Seed | $32,219,580 |
| Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
| Vesta Healthcare | September, 05 ,2024 | Series C | $65,000,000 |
| Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
| Be Biopharma | October, 23 ,2024 | Unknown | $82,000,000 |
| Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
| INNOVENTRIC | October, 30 ,2024 | Series B | $28,500,000 |
| Metsera | November, 14 ,2024 | Series B | $215,000,000 |
| Adcendo | November, 26 ,2024 | Series B | $135,000,000 |
| Indapta Therapeutics | December, 18 ,2024 | Unknown | $22,500,000 |
| Curevo Vaccine | March, 19 ,2025 | Series B | $110,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sympera AI | $10,000,000 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
